tokens: Some clinical trials that used lisdexamfetamine as an add-on therapy with a selective serotonin reuptake inhibitor ( SSRI ) or serotonin-norepinephrine reuptake inhibitor ( SNRI ) for treatment-resistant depression indicated that this is no more effective than the use of an SSRI or SNRI alone .